Small islet-like microbeads, avidin-covered agarose resins (AARs), were used as a model system for islet transplantation. Capability for specific [68Ga]Ga-DOTA-(PEG)2-biotin uptake and retention for either AARs or human islets conjugated with avidin by means of a heparin scaffold was studied in vitro. Biodistribution of the novel positron emission tomography (PET) tracer [68Ga]Ga-DOTA-(PEG)2-biotin was evaluated in mice treated by intraportal transplantation of AARs by ¦ÌPET/computed tomography and ex vivo organ distribution and compared with control mice.
AARs had high capability to bind [68Ga]Ga-DOTA-(PEG)2-biotin, close to 50 % of administrated tracer/¦Ìl in vitro (>0.25 MBq/¦Ìl). Avidin-tagged human islets could bind on average 2.2 % of administered tracer/¦Ìl. Specificity (>90 % ) and retention (>90 % after 1 h) were high for both AARs and avidin-tagged islets. Hepatic tracer uptake and retention were increased in mice transplanted with AARs [standardized uptake value (SUV)=2.6] compared to the untreated group (SUV=1.4). In vivo uptake of tracer to AARs was blocked by preadministration of unlabeled biotin.
Avidin-tagged islet-like objects can be tracked in hepatic volume after intraportal transplantation by using [68Ga]Ga-DOTA-(PEG)2-biotin and PET.